MedPath

Tobramycin and Dexamethasone

Tobramycin and Dexamethasone Ophthalmic Suspension USP, 0.3%/0.1% (Sterile)

Approved
Approval ID

5dda7621-5438-4522-8be0-bc2e8dc418c5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 26, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin and Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-416
Application NumberNDA050592
Product Classification
M
Marketing Category
C73594
G
Generic Name
Tobramycin and Dexamethasone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateAugust 25, 2009
FDA Product Classification

INGREDIENTS (2)

TOBRAMYCINActive
Quantity: 3 mg in 1 mL
Code: VZ8RRZ51VK
Classification: ACTIB
DEXAMETHASONEActive
Quantity: 1 mg in 1 mL
Code: 7S5I7G3JQL
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tobramycin and Dexamethasone - FDA Drug Approval Details